These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
94 related articles for article (PubMed ID: 8194595)
1. Alzheimer's beta-amyloid peptide specifically interacts with and is degraded by insulin degrading enzyme. Kurochkin IV; Goto S FEBS Lett; 1994 May; 345(1):33-7. PubMed ID: 8194595 [TBL] [Abstract][Full Text] [Related]
2. Degradation of Alzheimer's beta-amyloid protein by human and rat brain peptidases: involvement of insulin-degrading enzyme. McDermott JR; Gibson AM Neurochem Res; 1997 Jan; 22(1):49-56. PubMed ID: 9021762 [TBL] [Abstract][Full Text] [Related]
3. Degradation of soluble amyloid beta-peptides 1-40, 1-42, and the Dutch variant 1-40Q by insulin degrading enzyme from Alzheimer disease and control brains. Pérez A; Morelli L; Cresto JC; Castaño EM Neurochem Res; 2000 Feb; 25(2):247-55. PubMed ID: 10786709 [TBL] [Abstract][Full Text] [Related]
4. Involvement of insulin-degrading enzyme in insulin- and atrial natriuretic peptide-sensitive internalization of amyloid-β peptide in mouse brain capillary endothelial cells. Ito S; Ohtsuki S; Murata S; Katsukura Y; Suzuki H; Funaki M; Tachikawa M; Terasaki T J Alzheimers Dis; 2014; 38(1):185-200. PubMed ID: 23948938 [TBL] [Abstract][Full Text] [Related]
5. Insulin-degrading enzyme regulates the levels of insulin, amyloid beta-protein, and the beta-amyloid precursor protein intracellular domain in vivo. Farris W; Mansourian S; Chang Y; Lindsley L; Eckman EA; Frosch MP; Eckman CB; Tanzi RE; Selkoe DJ; Guenette S Proc Natl Acad Sci U S A; 2003 Apr; 100(7):4162-7. PubMed ID: 12634421 [TBL] [Abstract][Full Text] [Related]
15. The irreversible binding of amyloid peptide substrates to insulin-degrading enzyme: a biological perspective. de Tullio MB; Morelli L; Castaño EM Prion; 2008; 2(2):51-6. PubMed ID: 19098445 [TBL] [Abstract][Full Text] [Related]
16. Diet-induced insulin resistance promotes amyloidosis in a transgenic mouse model of Alzheimer's disease. Ho L; Qin W; Pompl PN; Xiang Z; Wang J; Zhao Z; Peng Y; Cambareri G; Rocher A; Mobbs CV; Hof PR; Pasinetti GM FASEB J; 2004 May; 18(7):902-4. PubMed ID: 15033922 [TBL] [Abstract][Full Text] [Related]
17. Multiple allosteric sites are involved in the modulation of insulin-degrading-enzyme activity by somatostatin. Tundo GR; Di Muzio E; Ciaccio C; Sbardella D; Di Pierro D; Polticelli F; Coletta M; Marini S FEBS J; 2016 Oct; 283(20):3755-3770. PubMed ID: 27579517 [TBL] [Abstract][Full Text] [Related]
18. Insulin-signaling Pathway Regulates the Degradation of Amyloid β-protein via Astrocytes. Yamamoto N; Ishikuro R; Tanida M; Suzuki K; Ikeda-Matsuo Y; Sobue K Neuroscience; 2018 Aug; 385():227-236. PubMed ID: 29932983 [TBL] [Abstract][Full Text] [Related]
19. CALHM1 ion channel elicits amyloid-β clearance by insulin-degrading enzyme in cell lines and in vivo in the mouse brain. Vingtdeux V; Chandakkar P; Zhao H; Blanc L; Ruiz S; Marambaud P J Cell Sci; 2015 Jul; 128(13):2330-8. PubMed ID: 25999473 [TBL] [Abstract][Full Text] [Related]
20. Structures of human insulin-degrading enzyme reveal a new substrate recognition mechanism. Shen Y; Joachimiak A; Rosner MR; Tang WJ Nature; 2006 Oct; 443(7113):870-4. PubMed ID: 17051221 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]